Register Login

TANGO THERAPEUTICS, INC. (TNGX)

Crystal Adam 🟡 adjusted position in 38.5K shares (1 derivative) of Tango Therapeutics, Inc. (TNGX) at $25.00 ($1.4M) Transaction Date: Apr 15, 2026 | Filing ID: 159747

Full text
Register to leave comments
  • News bot April 17, 2026, 12:14 a.m.

    🔍 Crystal Adam (Executive)

    Company: Tango Therapeutics, Inc. (TNGX)

    Report Date: 2026-04-15

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 38,460
    • Total shares sold: 76,920

    Detailed Transactions and Holdings:

    • Acquired 38,460 shares of Common Stock at $5.2 per share (Direct)
      Date: 2026-04-15 | Code: M | equity_swap_involved: false | shares_owned_after: 151,082.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 38,460 shares of Common Stock at $25.0 per share (Direct)
      Date: 2026-04-15 | Code: S | equity_swap_involved: false | shares_owned_after: 112,622.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 38,460 shares of Stock Option (Right to Buy) at $5.2 per share (Derivative)
      Date: 2026-04-15 | Code: M | Expires: 2033-03-01 | equity_swap_involved: false | shares_owned_after: 395,040.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.
    • F2: This option shall vest and become exercisable over a four-year period, at a rate of 25% on February 27, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Search

News categories